搜索临床试验以:OZ439 200 毫克原料药胶囊
总计166个结果
-
Medicines for Malaria VentureSyneos Health; Nucleus Network Ltd完全的
-
Medicines for Malaria Venture完全的
-
Chong Kun Dang Pharmaceutical完全的
-
Medicines for Malaria VentureUniversity of Cape Town终止
-
Hyundai Pharmaceutical Co., LTD.完全的
-
Medicines for Malaria VentureRichmond Pharmacology Limited完全的
-
SIGA TechnologiesBiomedical Advanced Research and Development Authority撤销
-
Medicines for Malaria VentureCross Research S.A.完全的
-
Reata, a wholly owned subsidiary of Biogen完全的
-
Hanlim Pharm. Co., Ltd.完全的慢性支气管炎急性加重 | 急性支气管炎大韩民国
-
TaiGen Biotechnology Co., Ltd.完全的
-
Reckitt Benckiser Healthcare (UK) LimitedPremier Research Group plc完全的
-
Imperial College Healthcare NHS TrustNational Institute for Health Research, United Kingdom完全的
-
Aclaris Therapeutics, Inc.完全的
-
dora pereiraUniversity of Oxford; University of Cambridge; Bangor University完全的
-
Texas Tech University Health Sciences Center完全的
-
Chung Shan Medical UniversityGolden Biotechnology Corporation终止
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.招聘中